These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28216300)

  • 21. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
    Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S
    Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
    Wang T; Hou J; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.
    Jin YJ; Termsarasab U; Ko SH; Shim JS; Chong S; Chung SJ; Shim CK; Cho HJ; Kim DD
    Pharm Res; 2012 Dec; 29(12):3443-54. PubMed ID: 22886625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
    Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
    Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
    Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
    Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
    Lee SY; Cho HJ
    Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
    Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.
    Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ
    Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma.
    Lee SY; Hong EH; Jeong JY; Cho J; Seo JH; Ko HJ; Cho HJ
    Biomater Sci; 2019 Nov; 7(11):4624-4635. PubMed ID: 31451819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
    Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
    J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.
    Youm I; Agrahari V; Murowchick JB; Youan BB
    Pharm Res; 2014 Sep; 31(9):2439-52. PubMed ID: 24643931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanocomplexes based on amphiphilic hyaluronic acid derivative and polyethylene glycol-lipid for ginsenoside rg3 delivery.
    Lee JY; Yang H; Yoon IS; Kim SB; Ko SH; Shim JS; Sung SH; Cho HJ; Kim DD
    J Pharm Sci; 2014 Oct; 103(10):3254-62. PubMed ID: 25112537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.